Dr. John V Marraccini , MD
Pathology - Forensic Pathology • South Miami, FL
6280 Sunset Dr, Suite 407
South Miami, FL 331434827
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. John Marraccini is listed in NPPES under Pathology - Forensic Pathology.
-
NPI assigned on November 1, 2006; this date does not establish years in practice.
-
Published CMS data list 1,173 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Rosuvastatin Calcium — 124 prescription fills, including refills.
- Atorvastatin Calcium — 117 prescription fills, including refills.
- Levothyroxine Sodium — 68 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 40 records in the table · Guide: How to read Medicare Part D prescriber data
-
Medicare Part D prescriptions went from 2,036 in 2020 to 1,173 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
6280 Sunset Dr
Suite 407
South Miami, FL 331434827
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Pathology - Forensic Pathology: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
2,900 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$17,438 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $199.97 across 10 records.
By nature of payment
- Food and Beverage: $199.97 across 10 records.
Reporting-company totals (3 largest of 6)
- GlaxoSmithKline, LLC.: $45.74 across 2 records.
- Eli Lilly and Company: $45.12 across 3 records.
- Exact Sciences Corporation: $36.85 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Marraccini has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Marraccini as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in South Miami and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Not enough clinicians listed under Pathology - Forensic Pathology in Florida have Medicare Part D data for 2024 to make a comparison.
Part D drug cost
Not enough clinicians listed under Pathology - Forensic Pathology in Florida have Medicare Part D data for 2024 to make a comparison.
1 active clinicians are listed under Pathology - Forensic Pathology with a practice address in South Miami, FL (53 in Florida).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 42% from 2,036 in 2020 to 1,173 in 2024.
- 2020: 2,036
- 2021: 2,010
- 2022: 1,656
- 2023: 1,301
- 2024: 1,173
-
30-day fills
30-day fills decreased 40% from 4,856 in 2020 to 2,900 in 2024.
- 2020: 4,856
- 2021: 4,870
- 2022: 4,067
- 2023: 3,152
- 2024: 2,900
-
Part D drug cost
Part D drug cost decreased 72% from $61,745 in 2020 to $17,438 in 2024.
- 2020: $61,745
- 2021: $45,751
- 2022: $33,159
- 2023: $22,696
- 2024: $17,438
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $175.97 in 2021 to $199.97 in 2025.
- 2021: $175.97
- 2022: $41.77
- 2023: $150.43
- 2024: $270.09
- 2025: $199.97
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): fewer than 11 records totaling $199.97.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $24.86 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $24.34 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
SHINGRIX | General | $23.51 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
PREVNAR 20 | General | $23.06 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
SHINGRIX | General | $22.23 |
| Exact Sciences Corporation |
Food and Beverage
In-kind items and services
|
The Cologuard Plus Collection Kit | General | $20.81 |
| Exact Sciences Corporation |
Food and Beverage
In-kind items and services
|
The Cologuard Plus Collection Kit | General | $16.04 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $15.73 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $15.19 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $14.20 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 124 | 10,980 | $1,433.36 | 48 |
| Atorvastatin Calcium | Atorvastatin Calcium | 117 | 10,367 | $1,365.97 | 40 |
| Levothyroxine Sodium | Levothyroxine Sodium | 68 | 5,931 | $850.14 | 27 |
| Amlodipine Besylate | Amlodipine Besylate | 56 | 5,040 | $517.71 | 23 |
| Lisinopril | Lisinopril | 43 | 3,880 | $556.56 | 16 |
| Metformin Hcl | Metformin Hcl | 42 | 3,780 | $384.55 | 14 |
| Hydrochlorothiazide | Hydrochlorothiazide | 38 | 3,360 | $476.70 | 16 |
| Pravastatin Sodium | Pravastatin Sodium | 37 | 3,330 | $553.77 | 15 |
| Allopurinol | Allopurinol | 35 | 3,015 | $362.87 | 11 |
| Trazodone Hcl | Trazodone Hcl | 33 | 2,078 | $167.45 | 15 |
| Azithromycin | Azithromycin | 30 | 135 | $71.09 | 27 |
| Eszopiclone | Eszopiclone | 30 | 941 | $520.83 | — |
| Simvastatin | Simvastatin | 28 | 2,505 | $394.08 | — |
| Omeprazole | Omeprazole | 28 | 2,550 | $486.84 | 11 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 25 | 144 | $156.73 | 23 |
| Losartan Potassium | Losartan Potassium | 25 | 2,250 | $361.12 | — |
| Pantoprazole Sodium | Pantoprazole Sodium | 25 | 2,130 | $289.34 | 12 |
| Metformin Hcl Er | Metformin Hcl | 25 | 2,063 | $242.93 | — |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 25 | 197 | $227.22 | 23 |
| Prednisone | Prednisone | 24 | 1,023 | $249.08 | 16 |
| Alprazolam | Alprazolam | 22 | 647 | $45.96 | 15 |
| Clonazepam | Clonazepam | 22 | 645 | $107.95 | — |
| Meloxicam | Meloxicam | 21 | 1,770 | $164.46 | — |
| Zolpidem Tartrate | Zolpidem Tartrate | 21 | 599 | $174.63 | — |
| Gabapentin | Gabapentin | 20 | 1,260 | $277.34 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207ZF0201X
A forensic pathologist is expert in investigating and evaluating cases of sudden, unexpected, suspicious and violent death as well as other specific classes of death defined by law. The forensic pathologist serves the public as coroner or medical examiner, or by performing medicolegal autopsies for such officials.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - FAMILY PRACTICE
I20081106000763
FL
6002975992
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Family Medicine
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Pathology (license number reported to NPPES: FL ME36275)
NPI status registered as active in NPPES database
Registered at 6280 SUNSET DR, SUITE 407, SOUTH MIAMI, FL 331434827 (Tel: 3056668858)
Registered at 6280 SUNSET DR, SUITE 407, SOUTH MIAMI, FL 331434827 (Tel: 3056668858)
Recorded as JOHN MARRACCINI, M.D.
Pathology (license number reported to NPPES: FL ME0036275)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Mailing Address
6280 Sunset Dr, Suite 407
South Miami, FL 331434827
Phone: 3056668858